Genetic heterogeneity between type 1a and type 1b insulin-dependent diabetes mellitus: HLA class II and TAP gene analysis

Tissue Antigens

Volumn 48, Issue 5, 1996, Pages 540-548

  Maugendre, D ^a   Alizadeh, M ^b   Gauthier, A ^b   Guilhem, I ^a   Pouillaud, C ^b   Genetet, B ^b   Allannic, H ^a   Semana, G ^b,c  

^a RENNES UNIVERSITY HOSPITAL   (France)

^b University Laboratory of Immunology   (France)

^c Lab Universitaire d'Immunologie   (France)

Author keywords

Genetic susceptibility; HLA class II; IDDM; MHC; TAP polymorphism

Indexed keywords

HLA ANTIGEN CLASS 2; HLA DQ ANTIGEN; HLA DR ANTIGEN;

ADULT; ALLELE; ARTICLE; AUTOIMMUNITY; CONTROLLED STUDY; ENDOCRINE DISEASE; ETIOLOGY; FEMALE; GENE FREQUENCY; GENETIC HETEROGENEITY; GENETIC SUSCEPTIBILITY; HAPLOTYPE; HLA TYPING; HUMAN; HUMAN CELL; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MAJOR HISTOCOMPATIBILITY COMPLEX; MALE; ONSET AGE; PRIORITY JOURNAL;

EID: 0030444017     PISSN: 00012815     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1399-0039.1996.tb02667.x     Document Type: Article

References (49)

1. Eisenbarth GS Type I diabetes mellitus. A chronic autoimmune disease. N Engl J Med 1986: 314: 122-9.
2. Thomson G, Robinson WP, Kuhner MK et al. Genetic heterogeneity, modes of inheritance, and risk estimates for a joint study of caucasians with insulin-dependent diabetes mellitus. Am J Hum Genet 1988: 43: 799-16.
3. Barnett AH, Eff C, Leslie RDG, Pyke DA Diabetes in identical twins: a study of 200 pairs. Diabetologia 1981: 20: 87-93.
4. Johnston C, Pyke DA, Cudworth AG, Wolf E. HLA-DR typing in identical twins with insulin-dependent diabetes: difference between concordant and discordant pairs. Br Med J 1983: 286: 253-5.
5. Todd JA Genetic control of autoimmunity in type I diabetes. Immunol Today 1990: 11: 122-8.
6. Wolf E, Spencer KM, Cudworth AG. The genetic susceptibility to type I (insulin dependent) diabetes: analysis of the HLA-DR association. Diabetologia 1983 24: 224-30.
7. Todd JA, Bell JI, MacDevitt HO. HLA-DQ gene contributes to susceptibility and resistance to insulin-dependent diabetes mellitus. Nature 1987: 329: 599-04.
8. Khalil I, Deschamps I, Lepage V, Al-Daccak R, Degos L, Hors J. Dose effect of cis- and trans-encoded HLA-DQa13 heterodimers in IDDM susceptibility. Diabetes 1992: 41: 378-84.
9. Neufeld M, Maclaren NK, Blizzard RM. Autoimmune polyglandular syndromes. Pediatr Ann 1980: 9: 154-82.
10. Bottazzo GF, Florin-Christensen, Doniach D. Islet-cell antibodies in diabetes mellitus with autoimmune polyendocrine deficiencies. Lancet 1974: ii: 1279-82.
11. Eisenbarth GS, Wilson PW, Ward F, Buckley C, Lebovitz H. The polyglandular failure syndrome: disease inheritance, HLA type and immune studies in patients and families. Ann Intern Med 1979: 91: 528-33.
12. Farid NR, Larsen B, Payne R, Noel EP, Sampson L. Polyglandular autoimmune disease and HLA. Tissue Antigens 1980: 16: 23-29.
13. Trence DL, Morley JE, Handwerger BS. Polyglandular autoimmune syndromes. Am J Med 1984: 77: 107-16.
14. Gu XF, Larger E, Clauser E, Assan R. Similarity of HLA-DQ profiles in adult-onset type 1 insulin-dependent diabetic patients with and without extra-pancreatic autoimmune diseases. Diab Metabol 1992: 18: 306-13.
15. Bignon JD, Semana G, Bardet S et al. Genetic susceptibility linked to DR4 haplotype in diabetes of type 1-a or associated with polyendocrinopathies (type 1-b). Tissue Antigens 1991: 38: 183-5.
16. Trowsdale J, Hanson I, Mockridge I, Beck S, Townsend A, Kelly A. Sequences encoded in the class II region of the MHC related to the "ABC" superfamily of transporters. Nature 1990: 348: 741-4.
17. Bahram S, Arnold D, Bresnahan M, Strominger JL, Spies T. Two putative subunits of a peptide pump encoded in the human major histocompatibility complex class II region. Proc Natl Acad Sci U S A 1991: 88: 10094-8.
18. Spies T, Bresnaham M, Bahram S et al. A gene in the Human major pathway. Nature 1990: 348: 744-7.
19. Spies T, De Mars R. Restored expression of major histocompatibility class I molecules by gene transfer of putative peptide transporter. Nature 1991: 351: 323-4.
20. Spies T, Cerundolo V, Colonna M, Creswell P, Townsend A, De Mars R. Presentation of endogenous viral antigens depend on putative peptide transporter heterodimer. Nature 1992: 355: 644-6.
21. Powis SH, Mockridge I, Kelly A et al. Polymorphism in a second ABC transporter gene located within the class II region of the human major histocompatibility complex. Proc Natl Acad Sci U S A 1992: 189: 1463-7.
22. Colonna M, Bresnahan M, Bahram S, Strominger JL, Spies T. Allelic variants of the human putative peptide transporter involved in antigen processing. Proc Natl Acad Sci U S A 1992: 89: 3932-6.
23. Van Endert PM, Lopez MT, Patel SD, Monaco JJ, McDevitt HO. Genomic polymorphism recombination and linkage disequilibrium in human major histocompatibility complex-encoded antigen-processing genes. Proc Natl Acad Sci U S A 1992: 89: 11594-7.
24. Carrington M, Spies T, Stephens JC, Mann DL. Haplotypic variation of the transporter associated with antigen processing (TAP) genes and their extension of HLA class II region haplotypes. Immunogenetics 1993: 37: 266-3.
25. Powis SH, Tonks S, Morkridge I, Kelly P, Bodmer JG, Trowsdale J. Alleles and haplotypes of the MHC-encoded ABC transporters TAP1 and TAP2. Immunogenetics 1993: 37: 373-80.
26. Bottazzo GF, Florin-Christensen A, Doniach D. Islet cell antibodies in diabetes mellitus with autoimmune polyendocrine deficiency. Lancet 1974: ii: 1279-1283
27. Kawasaki E, Moriuchi R, Takino H et al. Autoantibodies to 64,000-Mr islet cell protein in long-term type 1 (insulin-dependent) diabetic patients. Diabetologia 1992: 35: 748-52
28. Gray RS, Clarke BF. The clinical features of diabetes with coexisting autoimmune disease. Diabetologia 1981: 20: 602-608
29. Ludvigsson J, Samuelsson U, Beauforts SC et al. HLA-DR3 is associated with a more slowly progressive form of type I (insulin-dependent) diabetes. Diabetologia 1986: 29: 200-10
30. National Diabetes Data Group. Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. Diabetes 1979: 38: 183-5
31. Hmida S, Gauthier A, Dridi A et al. HLA Class II gene polymorphism in Tunisians. Tissue Antigens 1995, 45, 63-8
32. Noreen H, Hors J, Ronningen KS et al. HLA-DQA1 and - DQB1 polymorphism using polymerase chain reaction (PCR) oligotyping. In: Juji K, Aizawa M, Sasazuki T, ed. HLA 1991. Oxford: Oxford University Press, 1992: 477-484.
33. Bodmer JG, Marsh SGE, Albert et al. Nomenclature for factors of the HLA system, 1994. Tissue Antigens 1992: 44: 1-18
34. Mattiuz PL, Ihde D, Piazza A, Cepellini R, Bodmer WF. New approaches to the population genetics and aggregation analysis of the HLA system. In: Terasaki PI, ed. Histocompatibility testing 1970, Copenhagen: Munksgaard 1970: 193-06.
35. Imanishi T., Akaza T, Kimura A et al. Estimation of allele and haplotype frequencies for HLA and complement loci. In: Tsuji K, Aizawa M, Sasazuki T, ed. HLA 1991. Proceedings of the XIth International Histocompatibility Workshop and Conference. Vol. I. Oxford: Oxford University Press, 1992: 1: 76-9.
36. Tait BD, Mraz G, Harrison LC. Association of HLA-DQw3 (TA10) with type I diabetes occurs with DR3/4 but not DR1/4 patients. Diabetes 1988: 37: 926-9.
37. Nepom GT. Perspectives in diabetes. A unified hypothesis for the complex genetics of HLA associations with IDDM. Diabetes 1990: 30: 1153-7
38. Caillat-Zucman S, Bertin E, Timsit J, Boitard C, Assan R, Bach JF. Protection from insulin-dependent diabetes mellitus is linked to a peptide transporter gene. Eur J Immunol 1993: 23: 1784-8.
39. Jackson DG, Capra JD. TAP1 alleles in insulin-dependent diabetes mellitus: a newly defined centromeric boundary of disease susceptibility. Proc Natl Acad Sci U S A 1993: 90: 11079-83.
40. Martinez-Laso J, Martin-Villa J, Alvarez M, Martinez-Quiles N, Lledo G, Arnaiz-Villena A. Susceptibility to insulin dependent diabetes mellitus and short cytoplasmic ATP-binding domain TAP2*01 alleles. Tissue Antigens 1994: 44: 184-8.
41. Ronningen KS, Undlien DE, Ploski R, et al. Linkage disequilibrium between TAP2 variants and HLA class II alleles; no primary association between TAP2 variants and insulin-dependent diabetes mellitus. J Immunol 1993: 23: 1050-6.
42. Cucca F, Congia M, Trowsdale J, Powis SH. Insulin-dependent diabetes mellitus and the major histocompatibility complex peptide transporters TAP1 and TAP2: no association in a population with a high disease incidence. Tissue Antigens 1994: 44: 234-40.
43. Caillat-Zucman S, Daniel S, Djilali-Saiah I et al. Family study of linkage disequilibrium between TAP2 transporter and HLA class II genes: absence of TAP2 contribution to association with insulin-dependent diabetes mellitus. Hum Immunol 1995: 44: 80-7.
44. Powis SH, Rosenberg WMC, Hall M et al. TAP1 and TAP2 polymorphism in celiac disease. Immunogenetics 1993: 38: 345-50.
45. Marsal S, Hall MA, Panayi GS, Lanchbury JS. Association of TAP2 polymorphism with rheumatoid arthritis is secondary to allelic association with HLA-DRB1 Arthritis Rheum 1994: 4: 504-13.
46. Kellar-Wood HF, Powis SH, Gray J, Compston DAS. MHC-encoded TAP1 and TAP2 dimorphisms in multiple sclerosis. Tissue Antigens 1994: 43: 129-32.
47. Moins-Teisserenc H, Semana G, Alizadeh M et al. TAP2 gene polymorphism contributes to genetic susceptibility to multiple sclerosis. Hum Immunol 1995: 42: 195-02.
48. Campbell RD, Throwsdale J. Map of the human MHC. Immunol Today 1993: 14: 349.
49. Caillat-Zucman S, Garchon HJ, Timsit J et al. Age-dependent HLA genetic heterogeneity of type 1 insulin-dependent diabetes mellitus. J Clin Invest 1992: 90: 2242-50.